{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:59:53Z","timestamp":1772024393565,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11033-014-3509-7","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T05:21:31Z","timestamp":1404192091000},"page":"6263-6273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED ARTICLE: Relationships between\n                PON1 Q192R polymorphism and clinical outcome of\n            antiplatelet treatment after percutaneous coronary intervention: a\n            meta-analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Tong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Nian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"3509_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.amjcard.2011.03.050","volume":"108","author":"A Caggegi","year":"2011","unstructured":"Caggegi A, Capodanno D, Capranzano P, Chisari A, Ministeri M,\n                    Mangiameli A, Ronsivalle G, Ricca G et al (2011) Comparison of one-year outcomes\n                    of percutaneous coronary intervention versus coronary artery bypass grafting in\n                    patients with unprotected left main coronary artery disease and acute coronary\n                    syndromes (from the customize registry). Am J Cardiol 108:355\u2013359. doi:10.1016\/j.amjcard.2011.03.050","journal-title":"Am J Cardiol"},{"key":"3509_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.109.909473","volume":"122","author":"SF Mause","year":"2010","unstructured":"Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, Muller-Newen\n                    G, Soehnlein O, Weber C (2010) Platelet microparticles enhance the\n                    vasoregenerative potential of angiogenic early outgrowth cells after vascular\n                    injury. Circulation 122:495\u2013506. doi:10.1161\/CIRCULATIONAHA.109.909473","journal-title":"Circulation"},{"key":"3509_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/09537104.2011.567423","volume":"22","author":"T Lhermusier","year":"2011","unstructured":"Lhermusier T, Van Rothem J, Garcia C, Gratacap MP, Payrastre B\n                    (2011) Targeted drug therapy: the platelet side. Platelets 22:479\u2013484. doi:10.3109\/09537104.2011.567423","journal-title":"Platelets"},{"key":"3509_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/CIRCINTERVENTIONS.108.811380","volume":"1","author":"AK Chhatriwalla","year":"2008","unstructured":"Chhatriwalla AK, Bhatt DL (2008) Should dual antiplatelet therapy\n                    after drug-eluting stents be continued for more than one-year? Dual antiplatelet\n                    therapy after drug-eluting stents should be continued for more than one-year and\n                    preferably indefinitely. Circ Cardiovasc Interv 1:217\u2013225. doi:10.1161\/CIRCINTERVENTIONS.108.811380","journal-title":"Circ Cardiovasc Interv"},{"key":"3509_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2010.05.001","volume":"127","author":"D Tousoulis","year":"2010","unstructured":"Tousoulis D, Paroutoglou IP, Papageorgiou N, Charakida M,\n                    Stefanadis C (2010) Recent therapeutic approaches to platelet activation in\n                    coronary artery disease. Pharmacol Ther 127:108\u2013120. doi:10.1016\/j.pharmthera.2010.05.001","journal-title":"Pharmacol Ther"},{"key":"3509_CR6","doi-asserted-by":"publisher","first-page":"e52779","DOI":"10.1371\/journal.pone.0052779","volume":"8","author":"KW Park","year":"2013","unstructured":"Park KW, Park JJ, Kang J, Jeon KH, Kang SH, Han JK, Lee SE, Yang HM\n                    et al (2013) Paraoxonase 1 gene polymorphism does not affect clopidogrel\n                    response variability but is associated with clinical outcome after PCI. PLoS One\n                    8:e52779. doi:10.1371\/journal.pone.0052779","journal-title":"PLoS One"},{"key":"3509_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCGENETICS.111.960112","volume":"4","author":"D Trenk","year":"2011","unstructured":"Trenk D, Hochholzer W, Fromm MF, Zolk O, Valina CM, Stratz C,\n                    Neumann FJ (2011) Paraoxonase-1 Q192R polymorphism and antiplatelet effects of\n                    clopidogrel in patients undergoing elective coronary stent placement. Circ\n                    Cardiovasc Genet 4:429\u2013436. doi:10.1161\/CIRCGENETICS.111.960112","journal-title":"Circ Cardiovasc Genet"},{"key":"3509_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/00008571-200012000-00002","volume":"10","author":"WF Li","year":"2000","unstructured":"Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ,\n                    Furlong CE (2000) Catalytic efficiency determines the in vivo efficacy of pon1\n                    for detoxifying organophosphorus compounds. Pharmacogenetics\n                    10:767\u2013779","journal-title":"Pharmacogenetics"},{"key":"3509_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/CIRCINTERVENTIONS.111.963025","volume":"4","author":"JS Hulot","year":"2011","unstructured":"Hulot JS, Collet JP, Cayla G, Silvain J, Allanic F,\n                    Bellemain-Appaix A, Scott SA, Montalescot G (2011) CYP2C19 but not PON1 genetic\n                    variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical\n                    efficacy in post-myocardial infarction patients. Circ Cardiovasc Interv\n                    4:422\u2013428. doi:10.1161\/CIRCINTERVENTIONS.111.963025","journal-title":"Circ Cardiovasc Interv"},{"key":"3509_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/01.ATV.0000051702.38086.C1","volume":"23","author":"X Wang","year":"2003","unstructured":"Wang X, Fan Z, Huang J, Su S, Yu Q, Zhao J, Hui R, Yao Z et al\n                    (2003) Extensive association analysis between polymorphisms of PON gene cluster\n                    with coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc\n                    Biol 23:328\u2013334. doi:10.1161\/01.ATV.0000051702.38086.C1","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3509_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nm.2281","volume":"17","author":"HJ Bouman","year":"2011","unstructured":"Bouman HJ, Schomig E, van Werkum JW, Velder J, Hackeng CM,\n                    Hirschhauser C, Waldmann C, Schmalz HG et al (2011) Paraoxonase-1 is a major\n                    determinant of clopidogrel efficacy. Nat Med 17:110\u2013116. doi:10.1038\/nm.2281","journal-title":"Nat Med"},{"key":"3509_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/clpt.2011.194","volume":"90","author":"JP Lewis","year":"2011","unstructured":"Lewis JP, Fisch AS, Ryan K, O\u2019Connell JR, Gibson Q, Mitchell BD,\n                    Shen H, Tanner K et al (2011) Paraoxonase 1 (PON1) gene variants are not\n                    associated with clopidogrel response. Clin Pharmacol Ther 90:568\u2013574. doi:10.1038\/clpt.2011.194","journal-title":"Clin Pharmacol Ther"},{"key":"3509_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2165\/00003495-200767040-00013","volume":"67","author":"GL Plosker","year":"2007","unstructured":"Plosker GL, Lyseng-Williamson KA (2007) Clopidogrel: a review of\n                    its use in the prevention of thrombosis. Drugs 67:613\u2013646","journal-title":"Drugs"},{"key":"3509_CR14","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/dmd.30.11.1288","volume":"30","author":"JM Pereillo","year":"2002","unstructured":"Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P,\n                    Pascal M, Herbert JM et al (2002) Structure and stereochemistry of the active\n                    metabolite of clopidogrel. Drug Metab Dispos 30:1288\u20131295. doi:10.1124\/dmd.30.11.1288","journal-title":"Drug Metab Dispos"},{"key":"3509_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/nm.2386","volume":"17","author":"J Camps","year":"2011","unstructured":"Camps J, Joven J, Mackness B, Mackness M, Tawfik D, Draganov D,\n                    Costa LG, Paragh G et al (2011) Paraoxonase-1 and clopidogrel efficacy. Nat Med\n                    17:1041\u20131042. doi:10.1038\/nm.2386","journal-title":"Nat Med"},{"key":"3509_CR16","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.jacc.2011.11.068","volume":"59","author":"MJ Price","year":"2012","unstructured":"Price MJ, Murray SS, Angiolillo DJ, Lillie E, Smith EN, Tisch RL,\n                    Schork NJ, Teirstein PS et al (2012) Influence of genetic polymorphisms on the\n                    effect of high- and standard-dose clopidogrel after percutaneous coronary\n                    intervention: the gift (genotype information and functional testing) study. J Am\n                    Coll Cardiol 59:1928\u20131937. doi:10.1016\/j.jacc.2011.11.068","journal-title":"J Am Coll Cardiol"},{"key":"3509_CR17","doi-asserted-by":"publisher","first-page":"e39178","DOI":"10.1371\/journal.pone.0039178","volume":"7","author":"DY Chen","year":"2012","unstructured":"Chen DY, Wang CY, Wen MS, Lee TH, Chu Y, Hsieh MJ, Chang SH, Lee CH\n                    et al (2012) Paraoxonase-1 is not a major determinant of stent thrombosis in a\n                    taiwanese population. PLoS One 7:e39178. doi:10.1371\/journal.pone.0039178","journal-title":"PLoS One"},{"key":"3509_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa Scale\n                    for the assessment of the quality of nonrandomized studies in meta-analyses. Eur\n                    J Epidemiol 25:603\u2013605. doi:10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"3509_CR19","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1093\/bioinformatics\/bti536","volume":"21","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Ioannidis JP (2005) Hegesma: genome search\n                    meta-analysis and heterogeneity testing. Bioinformatics 21:3672\u20133673. doi:10.1093\/bioinformatics\/bti536","journal-title":"Bioinformatics"},{"key":"3509_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.295.6.676","volume":"295","author":"JL Peters","year":"2006","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006)\n                    Comparison of two methods to detect publication bias in meta-analysis. JAMA\n                    295:676\u2013680. doi:10.1001\/jama.295.6.676","journal-title":"JAMA"},{"key":"3509_CR21","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1538-7836.2011.04457.x","volume":"9","author":"G Campo","year":"2011","unstructured":"Campo G, Ferraresi P, Marchesini J, Bernardi F, Valgimigli M (2011)\n                    Relationship between paraoxonase q192r gene polymorphism and on-clopidogrel\n                    platelet reactivity over time in patients treated with percutaneous coronary\n                    intervention. J Thromb Haemost 9:2106\u20132108. doi:10.1111\/j.1538-7836.2011.04457.x","journal-title":"J Thromb Haemost"},{"key":"3509_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/eurheartj\/ehr155","volume":"32","author":"D Sibbing","year":"2011","unstructured":"Sibbing D, Koch W, Massberg S, Byrne RA, Mehilli J, Schulz S, Mayer\n                    K, Bernlochner I et al (2011) No association of paraoxonase-1 Q192R genotypes\n                    with platelet response to clopidogrel and risk of stent thrombosis after\n                    coronary stenting. Eur Heart J 32:1605\u20131613. doi:10.1093\/eurheartj\/ehr155","journal-title":"Eur Heart J"},{"key":"3509_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00228-012-1446-8","volume":"69","author":"XF Tang","year":"2013","unstructured":"Tang XF, Wang J, Zhang JH, Meng XM, Xu B, Qiao SB, Wu YJ, Chen J et\n                    al (2013) Effect of the CYP2C19 2 and 3 genotypes, abcb1 C3435T and pon1 Q192R\n                    alleles on the pharmacodynamics and adverse clinical events of clopidogrel in\n                    Chinese people after percutaneous coronary intervention. Eur J Clin Pharmacol\n                    69:1103\u20131112. doi:10.1007\/s00228-012-1446-8","journal-title":"Eur J Clin Pharmacol"},{"key":"3509_CR24","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.ijcard.2012.07.020","volume":"167","author":"JJ Verschuren","year":"2013","unstructured":"Verschuren JJ, Boden H, Wessels JA, van der Hoeven BL, Trompet S,\n                    Heijmans BT, Putter H, Guchelaar HJ et al (2013) Value of platelet\n                    pharmacogenetics in common clinical practice of patients with st-segment\n                    elevation myocardial infarction. Int J Cardiol 167:2882\u20132888. doi:10.1016\/j.ijcard.2012.07.020","journal-title":"Int J Cardiol"},{"key":"3509_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00041433-200406000-00005","volume":"15","author":"GS Getz","year":"2004","unstructured":"Getz GS, Reardon CA (2004) Paraoxonase, a cardioprotective enzyme:\n                    continuing issues. Curr Opin Lipidol 15:261\u2013267","journal-title":"Curr Opin Lipidol"},{"key":"3509_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cccn.2004.09.019","volume":"352","author":"LG Costa","year":"2005","unstructured":"Costa LG, Cole TB, Vitalone A, Furlong CE (2005) Measurement of\n                    paraoxonase (PON1) status as a potential biomarker of susceptibility to\n                    organophosphate toxicity. Clin Chim Acta 352:37\u201347. doi:10.1016\/j.cccn.2004.09.019","journal-title":"Clin Chim Acta"},{"key":"3509_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/clpt.2011.193","volume":"90","author":"T Simon","year":"2011","unstructured":"Simon T, Steg PG, Becquemont L, Verstuyft C, Kotti S, Schiele F,\n                    Ferrari E, Drouet E et al (2011) Effect of paraoxonase-1 polymorphism on\n                    clinical outcomes in patients treated with clopidogrel after an acute myocardial\n                    infarction. Clin Pharmacol Ther 90:561\u2013567. doi:10.1038\/clpt.2011.193","journal-title":"Clin Pharmacol Ther"},{"key":"3509_CR28","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","volume":"288","author":"SR Steinhubl","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C,\n                    Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following\n                    percutaneous coronary intervention: a randomized controlled trial. JAMA\n                    288:2411\u20132420. doi:10.1001\/jama.288.19.2411","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1007\/s11033-015-3902-x","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"record-id":"953"},{"DOI":"10.1007\/s11033-015-3902-x","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000}},{"DOI":"10.1007\/s11033-014-3509-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-014-3509-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3509-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:03:56Z","timestamp":1772021036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-014-3509-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3509-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]},"assertion":[{"value":"16 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}